PERRONE, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.613
NA - Nord America 1.492
AS - Asia 307
AF - Africa 4
OC - Oceania 1
Totale 3.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.488
PL - Polonia 780
RU - Federazione Russa 391
IT - Italia 154
IE - Irlanda 98
CN - Cina 90
SE - Svezia 83
SG - Singapore 83
HK - Hong Kong 76
DE - Germania 37
JO - Giordania 27
CH - Svizzera 14
FI - Finlandia 13
IN - India 13
VN - Vietnam 12
GB - Regno Unito 10
ES - Italia 9
AT - Austria 7
NL - Olanda 5
BE - Belgio 4
CI - Costa d'Avorio 4
TR - Turchia 4
CA - Canada 3
UA - Ucraina 3
DK - Danimarca 2
FR - Francia 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
Totale 3.417
Salva come PNG Salva come JPEG
Città #
Warsaw 776
Santa Clara 256
Fairfield 154
Chandler 129
Ashburn 114
Dublin 98
Houston 81
Cambridge 79
Seattle 78
Woodbridge 70
Singapore 69
Wilmington 59
Hong Kong 50
Ann Arbor 44
Florence 42
Beijing 39
Altamura 36
Lawrence 32
Princeton 27
Bremen 23
Buffalo 20
Shanghai 18
Boardman 16
Boston 15
Medford 15
New York 15
Bern 14
Kent 12
Mumbai 11
San Diego 10
Barcelona 9
Dong Ket 8
Vienna 7
Phoenix 6
Jacksonville 5
Los Angeles 5
Moscow 5
Norwalk 5
Abidjan 4
Cagliari 4
Dearborn 4
Falls Church 4
Brussels 3
Latina 3
Sinalunga 3
Toronto 3
Turin 3
Copenhagen 2
Guangzhou 2
Hillsboro 2
London 2
Meppel 2
Padova 2
Perugia 2
Pune 2
Radomsko 2
Sesto Fiorentino 2
Torun 2
West Jordan 2
Andover 1
Aprilia 1
Atlanta 1
Auckland 1
Baotou 1
Bethesda 1
Bologna 1
Cantagallo 1
Central District 1
Cercola 1
Empoli 1
Guidonia 1
Hangzhou 1
Hefei 1
Helsinki 1
Izmir 1
Kilburn 1
Kunming 1
Lappeenranta 1
Lisbon 1
Lucca 1
Misano Adriatico 1
Munich 1
Naaldwijk 1
New Bedfont 1
Newark 1
Nuremberg 1
Oggiono 1
Paceco 1
Palermo 1
Philadelphia 1
Quercegrossa 1
Ravenna 1
Redmond 1
Redwood City 1
Rovigo 1
Rui'an 1
San Cesario Di Lecce 1
Secaucus 1
Shenzhen 1
Siena 1
Totale 2.548
Salva come PNG Salva come JPEG
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 278
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 247
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 240
Druggable Targets in Pancreatic Adenocarcinoma 230
Identificazione di MTHFR 1298A>C come marcatore predittivo di sopravvivenza in due coorti di pazienti con carcinoma colorettale (stadio II e III) trattati con chemioterapia adiuvante a base di fluoropirimidine con o senza oxaliplatino 223
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 204
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 187
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 139
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 138
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 135
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 134
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 120
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 119
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 112
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 100
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 98
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 95
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 93
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 89
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 89
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 87
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 80
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 68
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 67
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 61
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 36
Totale 3.469
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020437 0 0 0 0 72 60 60 71 55 51 57 11
2020/2021383 32 40 3 46 46 34 35 21 36 48 20 22
2021/2022178 6 6 7 6 3 17 4 21 12 14 26 56
2022/2023576 47 116 34 57 36 86 59 28 69 1 12 31
2023/2024248 4 21 30 10 11 27 27 72 6 7 15 18
2024/2025850 56 128 89 236 341 0 0 0 0 0 0 0
Totale 3.469